Updates
** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%
** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay
** White House officials say government will give drugmakers price targets in next 30 days
** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5%
** "While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view," brokerage UBS says
** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。